AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to manufacture them.

Drugmaker AstraZeneca has teamed up with Indian digital health specialist Qure.ai and a clinical group in the UK to test an artificial intelligence-powered technology to help radiologists ...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first ...